- Home
- SNRE vs ALVO Comparison
SNRE vs ALVO Comparison
Compare SNRE & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNRE
- ALVO
- Stock Information
- Founded
- SNRE 2000
- ALVO 2013
- Country
- SNRE Switzerland
- ALVO Luxembourg
- Employees
- SNRE N/A
- ALVO N/A
- Industry
- SNRE Cable & Other Pay Television Services
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- SNRE Telecommunications
- ALVO Health Care
- Exchange
- SNRE Nasdaq
- ALVO Nasdaq
- Market Cap
- SNRE 3.4B
- ALVO 3.4B
- IPO Year
- SNRE N/A
- ALVO N/A
- Fundamental
- Price
- SNRE $53.25
- ALVO $8.29
- Analyst Decision
- SNRE
- ALVO Buy
- Analyst Count
- SNRE 0
- ALVO 1
- Target Price
- SNRE N/A
- ALVO $18.00
- AVG Volume (30 Days)
- SNRE 346.0K
- ALVO 162.8K
- Earning Date
- SNRE 04-29-2025
- ALVO 05-20-2025
- Dividend Yield
- SNRE 7.00%
- ALVO N/A
- EPS Growth
- SNRE N/A
- ALVO N/A
- EPS
- SNRE N/A
- ALVO N/A
- Revenue
- SNRE $3,330,464,145.00
- ALVO $491,978,000.00
- Revenue This Year
- SNRE N/A
- ALVO $33.92
- Revenue Next Year
- SNRE N/A
- ALVO $45.74
- P/E Ratio
- SNRE N/A
- ALVO N/A
- Revenue Growth
- SNRE N/A
- ALVO 426.85
- 52 Week Low
- SNRE $42.35
- ALVO $7.35
- 52 Week High
- SNRE $52.04
- ALVO $14.76
- Technical
- Relative Strength Index (RSI)
- SNRE N/A
- ALVO 32.92
- Support Level
- SNRE N/A
- ALVO $8.25
- Resistance Level
- SNRE N/A
- ALVO $8.98
- Average True Range (ATR)
- SNRE 0.00
- ALVO 0.55
- MACD
- SNRE 0.00
- ALVO -0.01
- Stochastic Oscillator
- SNRE 0.00
- ALVO 36.86
About SNRE Sunrise Communications AG American Depositary Shares representing Class A shares
Sunrise Communications AG is a telecommunications company. The company provides high-quality mobile, landline, broadband, and TV services to residential customers. The company also offers business customers 360-degree communications solutions and integrated ICT solutions for connectivity, security, and IoT from a single source to take companies forward in their quest for digitalization. It has three reportable segments being Residential customers; Business customers and Wholesale and Infrastructure and Support functions.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.